The significance of highlighting the oestrogen receptor low category in breast cancer

The latest ASCO/CAP guideline has recommended to report oestrogen receptor (ER) low cases (ER(lo); 1–10%) as “ER low positive category”, prompting us to compare the clinicopathologic features, biomarkers, survival and treatment of the ER(lo) cases with other subgroups (ER negative (ER(neg)) and ER h...

Descripción completa

Detalles Bibliográficos
Autores principales: Poon, Ivan K., Tsang, Julia Y., Li, Joshua, Chan, Siu-Ki, Shea, Ka-Ho, Tse, Gary M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555863/
https://www.ncbi.nlm.nih.gov/pubmed/32713939
http://dx.doi.org/10.1038/s41416-020-1009-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555863/
https://www.ncbi.nlm.nih.gov/pubmed/32713939
http://dx.doi.org/10.1038/s41416-020-1009-1

Ejemplares similares